https://www.selleckchem.com/pr....oducts/super-tdu.htm
A meropenem regimen of 750mg q 8h was recommended for Asian critically ill patients receiving 2 different CRRT modalities with standard and high effluent rates. Clinical validation of these results is needed. A meropenem regimen of 750 mg q 8 h was recommended for Asian critically ill patients receiving 2 different CRRT modalities with standard and high effluent rates. Clinical validation of these results is needed.Recently, several trials demonstrated the safety of omitting axillary lymph node dissection in clinically N0 patients wit
Mi piace
Commento
Condividi
